ENTRY       D11616            Mixture   Drug
NAME        Aspirin and omeprazole;
            Yosprala (TN)
PRODUCT     YOSPRALA (Genus Lifesciences)
            YOSPRALA (PHARMACEUTIKA)
COMPONENT   Aspirin [DR:D00109], Omeprazole [DR:D00455]
CLASS       Metabolizing enzyme substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Product: D11616<US>
EFFICACY    Anti-ulcerative
COMMENT     Prevention of aspirin-associated gastric ulcers
            Omeprazole is metabolized by CYP2C19 with some contribution from CYP3A4.
METABOLISM  Enzyme: CYP2C19 [HSA:1557]; CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01639  CYP2C19 substrate
               D11616  Aspirin and omeprazole
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D11616  Aspirin and omeprazole
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11616
DBLINKS     CAS: 1259513-22-8
            PubChem: 405226483
///
